Back to search
Difluorodeoxycytidine (dFdC) — gemcitabine: A phase I study
Data up to Jan 2025
Published1992
Citations75
References4
Total Citations Per Year
Abstract
References (4)
Reporting results of cancer treatment
1981 • 7,916 citations
A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.
1991 • 755 citations
Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).
1990 • 670 citations
Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine.
1988 • 509 citations
Cited By (0)
Loading...